Lenscrafters#986 | |
554 Pinnacle Pkwy, Ste 701, Bristol, Tennessee 37620 | |
(423) 764-4066 |
Name | Lenscrafters#986 |
---|---|
Organization Name | Luxottica Of America Inc |
Location | 554 Pinnacle Pkwy, Ste 701, Bristol, Tennessee 37620 |
Type | Eyewear Supplier (Equipment, not the service) |
Phone | (423) 764-4066 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Republicans cite their 2.5-point defeat in the Virginia governor's race as proof that Ken Cuccinelli would have reversed his fortunes if he'd hammered earlier and longer on Obamacare, an issue the attorney general said tightened the contest in its final days (Davis and McCormick, 11/7).
The UK will be transformed into a global hub for radiotherapy research, pioneering the use of the latest techniques such as FLASH radiotherapy and artificial intelligence, with a new £56 million research network announced by Cancer Research UK today (Monday).
The reviews may not be good, but people are visiting the new health care web sites, according to the new AP-GfK poll. In addition, experts offer possible reasons for the problems that continue to plague the federal health insurance web site. Meanwhile, various news outlets examine how certain states are faring with the federal and state exchanges.
Novartis today announced the US Food and Drug Administration approved the expanded use of Zykadia (ceritinib) to include the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive, as detected by an FDA-approved test.
Research led by Queen Mary University of London has revealed novel insights into the molecular circuitry controlling cancer cell growth and spread.
› Verified 7 days ago
NPI Number | 1568531135 |
Organization Name | LUXOTTICA OF AMERICA INC. |
Doing Business As | LENSCRAFTERS #986 |
Type | Eyewear Supplier (Equipment, not the service) |
Address | 554 Pinnacle Pkwy Ste 701, Bristol, TN 37620 |
Phone Number | 423-764-4066 |
News Archive
Republicans cite their 2.5-point defeat in the Virginia governor's race as proof that Ken Cuccinelli would have reversed his fortunes if he'd hammered earlier and longer on Obamacare, an issue the attorney general said tightened the contest in its final days (Davis and McCormick, 11/7).
The UK will be transformed into a global hub for radiotherapy research, pioneering the use of the latest techniques such as FLASH radiotherapy and artificial intelligence, with a new £56 million research network announced by Cancer Research UK today (Monday).
The reviews may not be good, but people are visiting the new health care web sites, according to the new AP-GfK poll. In addition, experts offer possible reasons for the problems that continue to plague the federal health insurance web site. Meanwhile, various news outlets examine how certain states are faring with the federal and state exchanges.
Novartis today announced the US Food and Drug Administration approved the expanded use of Zykadia (ceritinib) to include the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive, as detected by an FDA-approved test.
Research led by Queen Mary University of London has revealed novel insights into the molecular circuitry controlling cancer cell growth and spread.
› Verified 7 days ago
News Archive
Republicans cite their 2.5-point defeat in the Virginia governor's race as proof that Ken Cuccinelli would have reversed his fortunes if he'd hammered earlier and longer on Obamacare, an issue the attorney general said tightened the contest in its final days (Davis and McCormick, 11/7).
The UK will be transformed into a global hub for radiotherapy research, pioneering the use of the latest techniques such as FLASH radiotherapy and artificial intelligence, with a new £56 million research network announced by Cancer Research UK today (Monday).
The reviews may not be good, but people are visiting the new health care web sites, according to the new AP-GfK poll. In addition, experts offer possible reasons for the problems that continue to plague the federal health insurance web site. Meanwhile, various news outlets examine how certain states are faring with the federal and state exchanges.
Novartis today announced the US Food and Drug Administration approved the expanded use of Zykadia (ceritinib) to include the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive, as detected by an FDA-approved test.
Research led by Queen Mary University of London has revealed novel insights into the molecular circuitry controlling cancer cell growth and spread.
› Verified 7 days ago
Breast Prostheses & Orthotics Inc Type: Medicare Supplier Location: 1850 Edgemont Ave, Bristol, Tennessee 37620 Phone: (423) 573-8500 | |
Bristol Orthotics & Prosthetics Inc Type: Prosthetic/Orthotic Supplier Location: 553 Highway 126, Bristol, Tennessee 37620 Phone: (423) 968-4442 | |
Visionworks Doctors Of Type: Eyewear Supplier (Equipment, not the service) Location: 1262 Volunteer Parkway, Bristol, Tennessee 37620 Phone: (423) 989-3737 | |
H Johnson Pharmacy Type: Pharmacy Location: 520 Bluff City Hwy, Bristol, Tennessee 37620 Phone: (423) 968-2895 | |
Food City Pharmacy #617 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1430 Volunteer Pkwy, Bristol, Tennessee 37620 Phone: (423) 968-2222 |